Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04280718
Brief Title: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (ADHERE+)

First Submitted : February 20, 2020
First Submitted that Met QC Criteria : February 20, 2020
First Posted : February 21, 2020

Last Update Submitted that Met QC Criteria : September 16, 2021
Last Update Posted : September 17, 2021